药师干预对血必净注射液临床合理用药的促进效果分析
|
摘要
目的:探讨药师干预对医院合理使用血必净注射液的作用。方法:选取2018年1～12月我院实施药师干预期间采用血必净注射液的120例患者为观察组,以2017年1～12月在我院未实施药师干预期间的120例血必净注射液用药患者为对照组。观察组采取药师干预用药,对照组未予以药师干预。分别比较两组血必净注射液合理使用情况,两组不良反应发生情况以及患者满意度。结果:观察组血必净注射液使用指征合理率、使用剂量合理率以及使用疗程合理率分别为82.50%、91.67%、75.00%,均明显高于对照组的47.50%、64.17%、37.50%。观察组恶心、便血、腹泻、过敏性休克发生率分别为9.17%、0.83%、2.50%、0.83%,均明显低于对照组的20.00%、5.83%、9.17%、6.67%。观察组满意度为95.83%,明显高于对照组的85.00%。结论:药师干预可有效提高血必净注射液合理使用率,同时降低不良反应发生风险,提高满意度。
Objective:To explore the effect of pharmacist intervention on rational use of Xuebijing injection in hospitals. Methods:120 patients who used Xuebijing injection during the period of pharmacist intervention in our hospital from January 2018 to December 2018 were selected as observation group,and 120 patients who did not use Xuebijing injection during the period of pharmacist intervention in our hospital from January to December 2017 were selected as control group.The observation group was intervened by pharmacists,but the control group was not intervened by pharmacists. The rational use of Xuebijing injection,adverse reactions and patient satisfaction were compared between the two groups.Results:The observation group of blood will net injection using indications GeLiLv,using dose GeLiLv and treatment were 82.50%,91.67%,75.00%,47.50%,which were significantly higher than the control group of 64.17%,37.50%.Observation group of nausea,stool,diarrhea,anaphylactic shock incidence was 9.17%,0.83%,2.50%,0.83%,which were significantly lower than the control group of 20.00%,5.83%,9.17%,6.67%.The satisfaction of patients in the observation group was 95.83%,which was significantly higher than 85.00% in the control group.Conclusion:Pharmacist intervention can effectively improve the rational use rate of Xuebijing injection,reduce the risk of adverse reactions and improve patient satisfaction.
Objective:To explore the effect of pharmacist intervention on rational use of Xuebijing injection in hospitals. Methods:120 patients who used Xuebijing injection during the period of pharmacist intervention in our hospital from January 2018 to December 2018 were selected as observation group,and 120 patients who did not use Xuebijing injection during the period of pharmacist intervention in our hospital from January to December 2017 were selected as control group.The observation group was intervened by pharmacists,but the control group was not intervened by pharmacists. The rational use of Xuebijing injection,adverse reactions and patient satisfaction were compared between the two groups.Results:The observation group of blood will net injection using indications GeLiLv,using dose GeLiLv and treatment were 82.50%,91.67%,75.00%,47.50%,which were significantly higher than the control group of 64.17%,37.50%.Observation group of nausea,stool,diarrhea,anaphylactic shock incidence was 9.17%,0.83%,2.50%,0.83%,which were significantly lower than the control group of 20.00%,5.83%,9.17%,6.67%.The satisfaction of patients in the observation group was 95.83%,which was significantly higher than 85.00% in the control group.Conclusion:Pharmacist intervention can effectively improve the rational use rate of Xuebijing injection,reduce the risk of adverse reactions and improve patient satisfaction.
引文
[1]何巍,穆晓东,加慧.血必净注射液联合替加环素治疗鲍曼不动杆菌肺部感染的临床效果[J].中国当代医药,2019,26(5):31-33.
[2]李婉慧,李辉,李莉,等.2013—2017年哈励逊国际和平医院儿科清热解毒类中药注射剂用药分析[J].现代药物与临床,2018,033(003):686-690.
[3]周丽平,贺丹丹,江芳芳,等.医护协作临床新药管理制度在合理用药中的应用效果[J].解放军护理杂志,2019,36(1):70-72.
[4]姜学斌,王顺华.临床药师开展老年慢性病患者用药管理促进合理用药的作用探讨[J].中国医院用药评价与分析,2018,18(9):1273-1274.
[5]卢小利,卢伶俐,张弦.品管圈活动在降低急诊护士用药失误中的临床价值分析[J].中国医药科学,2018,8(15):155-158.
[6]唐洁,吴海宽,李玉琴,等.医院活血化瘀中药注射剂临床使用PDCA管理成效[J].解放军医院管理杂志,2018,25(8):795-797.
[7]郭华,任艳丽,王培,等.血必净注射液的不良反应文献分析[J].安徽医药,2017,21(8):1548-1551.
[8]孙坤,艾超.医院门诊前置处方审核分析及改进[J].中国药业,2017,26(22):92-95.
[9]徐惠惠,金丽娜,曹樟全,等.血必净和乌司他丁分别联合常规治疗慢性阻塞性肺疾病急性加重期合并全身炎症反应综合征疗效比较[J].中国药师,2017,20(5):864-866.
[10]沈珠,鲍君杰,陶宏,等.临床药师对中药注射剂重点监测品种的合理性评价[J].中国药事,2018,32(6):815-817.
[11]宦娣,王蕾,李杰,等.药学干预提升血必净注射液合理使用率效果分析[J].中国药业,2017,26(24):71-73.
[12]胡国仕,胡艳芬,徐文云,等.2013-2016年昭通市第一人民医院中药注射剂应用分析[J].中国医院用药评价与分析,2017,17(3):403-405.
[13]王晓剑,邓雪娥.我院静脉用药调配中心不合理用药干预效果分析[J].中国现代医生,2017,55(10):105-108.
[14]陈彬,万兴富,王家焕,等.血必净注射液联合乌司他丁在重症肺炎并脓毒症患者中的应用观察[J].中国中医急症,2017,26(11):2008-2010.
[15]王青富.血必净注射液对经皮肾镜碎石术后全身炎症反应综合征患者炎症反应的影响[J].中国合理用药探索,2017,14(10):23-25.
[2]李婉慧,李辉,李莉,等.2013—2017年哈励逊国际和平医院儿科清热解毒类中药注射剂用药分析[J].现代药物与临床,2018,033(003):686-690.
[3]周丽平,贺丹丹,江芳芳,等.医护协作临床新药管理制度在合理用药中的应用效果[J].解放军护理杂志,2019,36(1):70-72.
[4]姜学斌,王顺华.临床药师开展老年慢性病患者用药管理促进合理用药的作用探讨[J].中国医院用药评价与分析,2018,18(9):1273-1274.
[5]卢小利,卢伶俐,张弦.品管圈活动在降低急诊护士用药失误中的临床价值分析[J].中国医药科学,2018,8(15):155-158.
[6]唐洁,吴海宽,李玉琴,等.医院活血化瘀中药注射剂临床使用PDCA管理成效[J].解放军医院管理杂志,2018,25(8):795-797.
[7]郭华,任艳丽,王培,等.血必净注射液的不良反应文献分析[J].安徽医药,2017,21(8):1548-1551.
[8]孙坤,艾超.医院门诊前置处方审核分析及改进[J].中国药业,2017,26(22):92-95.
[9]徐惠惠,金丽娜,曹樟全,等.血必净和乌司他丁分别联合常规治疗慢性阻塞性肺疾病急性加重期合并全身炎症反应综合征疗效比较[J].中国药师,2017,20(5):864-866.
[10]沈珠,鲍君杰,陶宏,等.临床药师对中药注射剂重点监测品种的合理性评价[J].中国药事,2018,32(6):815-817.
[11]宦娣,王蕾,李杰,等.药学干预提升血必净注射液合理使用率效果分析[J].中国药业,2017,26(24):71-73.
[12]胡国仕,胡艳芬,徐文云,等.2013-2016年昭通市第一人民医院中药注射剂应用分析[J].中国医院用药评价与分析,2017,17(3):403-405.
[13]王晓剑,邓雪娥.我院静脉用药调配中心不合理用药干预效果分析[J].中国现代医生,2017,55(10):105-108.
[14]陈彬,万兴富,王家焕,等.血必净注射液联合乌司他丁在重症肺炎并脓毒症患者中的应用观察[J].中国中医急症,2017,26(11):2008-2010.
[15]王青富.血必净注射液对经皮肾镜碎石术后全身炎症反应综合征患者炎症反应的影响[J].中国合理用药探索,2017,14(10):23-25.